Update for Countries and Regional Partners Requesting Gavi Post-transition Support

In November 2017, the Gavi Board approved continued Gavi Alliance engagement with transitioned countries and a budget allocation of up to US$30m to support these countries until 2020. Support is being provided for technical assistance in key programmatic areas, including supply chain, LMC and data, paying special attention to innovative approaches and government commitment to their long-term sustainability.

In 2018, Gavi elaborated guidance outlining principles for the post-transition engagement and informing the countries and partners on how to operationalize this support. In February 2019, Gavi updated the guidance incorporating feedback from partners, as well as including examples and lessons learnt following the first round of reviews of PTE support requests. The revised guidance is now clearer and better communicates the need for a strong rationale based on a set of guiding principles for approval. It promotes increased dialogue and collaboration between stakeholders at the country, regional and global level, including the Secretariat. The timeframe for submission of support requests is also now flexible.

Eight out of fourteen eligible countries have seen their post-transition support requests approved: Armenia, Bhutan, Bolivia, Georgia, Guyana, Indonesia, Kiribati and Moldova. As an example of post-transition engagement, Guyana’s post-transition support is targeted to specifically help reach most remote populations with innovative approaches (including testing new technologies such as drones), as well as address time-sensitive challenges linked to recent influx of migrants from Venezuela posing epidemiology risks and putting stress on health sector in the long run. The Alliance’s support will also be catalytic as the government is co-investing in the supported activities and has committed to provide the necessary resources that will be needed to sustain them.

Support to transitioned countries is also being complemented by funding “global public goods”, such as peer-learning platforms (LNCT, VPPN), strengthening of technical capacity on health and immunization financing at regional level to support domestic immunization financing, implementation of NHA/SHA, revision of cMYPs, etc.

In the coming weeks, Gavi expects further support requests from 6 countries and 4 regional requests, as several countries and regional partners are working on finalizing their proposals in dialogue with the Gavi Secretariat. Please contact the Secretariat if you need further information or guidance on the post-transition engagement process: jwisniewska@gavi.org.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

COVAX Application Materials for AMC Eligible Economies Now Available

The COVAX Facility released the application and guidance documents (“application package”) for eligible economies to (i) confirm participation in the COVAX Facility and (ii) request support as part of COVAX. This comprises COVID-19 vaccines, as well as Cold Chain Equipment and Technical Assistance needed to prepare for the delivery of COVID-19 vaccines.  All 92 AMC Eligible … Read More

COVID-19: Gavi steps up response to pandemic

Gavi, the Vaccine Alliance, will provide US$ 29 million in urgent initial funding to 13 lower-income countries to support their response to COVID-19, helping them to protect health care workers with personal protective equipment (PPE), perform vital surveillance and training, and fund diagnostic tests. There are further requests or interest from 21 countries, meaning more … Read More

Center for Global Development – Global Immunization and Gavi: Five Priorities for the Next Five Years

Below is an excerpt from the Center for Global Development’s overview note.  Child vaccination remains among the most cost-effective uses of public and aid monies.[1] In a highly contested funding environment where priorities must be set for the allocation of scarce concessional resources, investment in expanding the availability and coverage of cost-effective vaccination must come … Read More